» Articles » PMID: 36147176

Severe Hemolysis with Negative Direct Antiglobulin Test: A Case Report

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2022 Sep 23
PMID 36147176
Authors
Affiliations
Soon will be listed here.
Abstract

A 49-year-old woman with type 2 diabetes mellitus (T2DM) presented to the emergency department. Her examination showed marked pallor, exhaustion, lethargy, yellowish eyes, anorexia, nausea and vomiting. Hematuria; negative standard direct antiglobulin test (DAT); normal glucose 6 phosphate dehydrogenase (G6PD); hemoglobin (Hb), 4.8 g/dl; Mean cell volume (MCV), 91fl; platelet count, 233 × 10/L; Total bilirubin, 7.0 mg/dl; Glucose, 316 mg/dl; lactate dehydrogenase (LDH), 1750U/L. Undoubtedly, therapeutic panel should have been used for hemolytic anemia. Intravenous (IV) fluids and 2 units of packed cell were transfused. Methylprednisolone with rituximab were started for the patient. After 3 weeks of the patient admission, she was discharged home with stable vital signs and Hb, 10 g/dl. We concluded in the cases that presented along with a severe drop in Hb and evidence of hemolysis which non immune hemolytic anemia is excluded in spite of negative standard DAT limited transfusion besides corticosteroids combined with rituximab, could be helpful in saving the patient.

Citing Articles

Deciphering Paroxysmal Nocturnal Hemoglobinuria: An Unusual Paradigm of Hemolytic Anemia.

Athota S, Gopalan S, Arthur P, Jayaram A, Satish A Cureus. 2024; 16(8):e67194.

PMID: 39295707 PMC: 11409906. DOI: 10.7759/cureus.67194.


Management of autoimmune haemolytic anaemia in low-to-middle income countries: current challenges and the way forward.

Datta S, Berentsen S Lancet Reg Health Southeast Asia. 2024; 23:100343.

PMID: 38601175 PMC: 11004394. DOI: 10.1016/j.lansea.2023.100343.

References
1.
Kulpa J, Skrabs C, Simanek R, Valent P, Panzer S, Lechner K . Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia. Wien Klin Wochenschr. 2015; 128(7-8):234-7. DOI: 10.1007/s00508-015-0863-y. View

2.
WORLLEDGE S, Blajchman M . The autoimmune haemolytic anaemias. Br J Haematol. 1972; 23:Suppl:61-9. DOI: 10.1111/j.1365-2141.1972.tb03505.x. View

3.
Jager U, Barcellini W, Broome C, Gertz M, Hill A, Hill Q . Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2019; 41:100648. DOI: 10.1016/j.blre.2019.100648. View

4.
Barcellini W, Fattizzo B, Zaninoni A . Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J Blood Med. 2019; 10:265-278. PMC: 6690850. DOI: 10.2147/JBM.S190327. View

5.
Segel G, Lichtman M . Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis. 2014; 52(4):152-60. DOI: 10.1016/j.bcmd.2013.12.003. View